April 2 2020

HITTING THE TARGET: Approvals for Companion Tests Rise in Step With Targeted Agents

April 18, 2020

Clinical Articles

Expanded indications in the treatment of cancers with novel therapy biomarkers were a notable result of drug approvals in the past year. In order to facilitate the identification of these molecular markers, more targeted agents are being approved with associated companion diagnostics, made evident by 3 such tests approved in 2019.

Study Explores Plasma Tumor Mutational Burden as Biomarker in NSCLC

April 20, 2020

Clinical Articles

“We can predict how a patient responds if PD-L1 levels are close to 100% or close to zero. But we cannot say [with certainty] that a patient with PD-L1 of 30% is going to have significantly different outcomes than a patient with PD-L1 of 40%.”

COVID-19 Vaccine Response Reminds National Leaders About Importance of Clinical Research

April 25, 2020

Clinical Articles

"This infectious disease would have likely wiped out many communities only decades ago. It is true that our highly connected and peripatetic society may have increased exposures across the world. Yet, we have risen to the occasion and implemented public health screening, testing, and treatment strategies."

Patients With Pretreated Sarcoma May Derive Benefit From Various Immunotherapy Combinations

April 15, 2020

Clinical Articles

Combination therapy strategies involving immune checkpoint inhibitors and a secondary agent have shown promise across sarcoma subtypes, according to analysis of clinical trial data that were presented at the European Society for Medical Oncology Sarcoma & GIST Symposium 2020, held in Milan, Italy.

Molecular Drivers of Cancer to Be Focus of Discussions at Breast Cancer Conferences

April 16, 2020

Clinical Articles

As the breast cancer setting quickly changes with each advancement, physicians who care for these patients will need to know how to apply these emerging treatments to the standards of care in their practice.

Oncologists Scramble to Shift Resources, Develop New Protocols in Response to Novel Coronavirus

April 17, 2020

Clinical Articles

From reprioritizing office visits to rescheduling surgical procedures and even delaying clinical trials, coronavirus disease 2019 has affected every facet of life on a global scale. Oncologists who are already challenged to keep their patients healthy from more run-off-the-mill infections must now contend with a new pathogen.